Frazier Life Sciences Acquisition Corp. II FLSC
Annual
Quarterly
No annual revenue total was found in Frazier Life Sciences Acquisition Corp. II's SEC filings.
Frazier Life Sciences Acquisition Corp. II (FLSC) files with the SEC under industry code 6770, Blank Checks.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- FLSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Palo Alto, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2153598
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 22, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Oct 15, 2026 | Oct 13, 2026 |
All 22 Frazier Life Sciences Acquisition Corp. II SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.